Ares Capital (ARCC) Q3 2026 Earnings Call Transcript

Ares Capital reported third-quarter 2026 core EPS of $0.46, versus $0.47 in the prior quarter, and agreed to acquire MidCap Financial Investment Corporation in a deal management expects to be modestly accretive to core EPS. NAV was $19.31 per share, down $0.04 sequentially; nonaccruals were 2.4% of investments at amortized cost and 1.4% at fair value, while pro forma available liquidity was approximately $7 billion. Ares declared a fourth-quarter dividend of $0.48 per share and reported $2.1 billion of quarterly investment commitments, with market volatility and longer deal timelines tempering activity.

Analysis

The setup is modestly constructive for ARCC, but the acquisition is a scale-and-sourcing option, not yet an earnings inflection. Its value depends on retaining attractive acquired loans, realizing the purchase discount without credit deterioration, and converting new borrower/sponsor links into future originations. Because some assets may be reviewed for allocation to Ivy Hill-managed vehicles, track what ARCC itself retains and the economics of any transfers; headline portfolio growth need not equal equivalent balance-sheet growth. Scale and funding access could widen ARCC’s relative advantage over smaller BDCs when deal markets are choppy, while competitors may face tougher competition for incumbent borrower relationships.

The near-term tension is distribution quality: core earnings are below the regular dividend, while spillover income supports payments but is not a substitute for recurring coverage. Higher base rates help reported income with a reset lag, yet also pressure weaker borrowers; the marginal credit loss could offset the yield benefit if rates remain elevated. Over 1–3 months, watch deal backlog conversion, acquisition closing updates, and credit marks; over 6–18 months, asset retention, realized discount accretion, and nonaccrual formation determine whether strategic scale earns its keep. Management’s accretion and credit characterizations are forecasts, not independently verified outcomes.

No aggressive event trade before terms, closing, and valuation are clearer. A measured relative-value long ARCC versus a diversified BDC basket is defensible only if ARCC’s relative price has not already fully capitalized the claimed funding and sourcing advantage. Falsify on deterioration in NAV or nonaccruals, weak acquired-asset retention/realizations, or persistent core-earnings shortfall against the dividend.

Key Decisions for Investors

• Avoid chasing ARCC solely on the announced acquisition. Reassess after closing disclosures establish acquired-asset marks, ARCC retention versus Ivy Hill allocation, and the realized funding mix.
• Watch ARCC’s next reports for recurring core EPS coverage of the dividend, NAV direction, nonaccruals, and conversion of backlog to funded investments. Treat spillover as a buffer, not proof of ongoing dividend coverage.
• If relative valuation remains attractive after those checks, consider a modest long ARCC versus a diversified BDC basket; exit or avoid if NAV/nonaccrual metrics weaken or acquisition accretion fails to emerge over subsequent quarters. No standalone trade in MFIC, ARES, or WFC is supported by the information provided.